Proteomic insights into inflammatory airway diseases

Current Proteomics

Volumn 8, Issue 2, 2011, Pages 84-96

  Brasier, Allan R ^a   Calhoun, William J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Asthma; inflammation; innate immunity; proteomics; Reactive oxygen species (ros); RIG I; tandem affinity purification molecular profiling

Indexed keywords

ARGINASE; CARD RNA HELICASE; GLUCOCORTICOID; GLUCOSE REGULATED PROTEIN 78; GLYCOLYTIC ENZYME; HEAT SHOCK PROTEIN; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; PEROXIREDOXIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; RNA HELICASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; BREATH ANALYSIS; BRONCHUS BIOPSY; CELLULAR IMMUNITY; CELLULAR STRESS RESPONSE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG TARGETING; ENZYME ACTIVITY; EXHALED BREATH CONDENSATE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LUNG LAVAGE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SIGNAL TRANSDUCTION; SPUTUM ANALYSIS; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; VIRAL BRONCHIOLITIS; VIRUS REPLICATION;

EID: 79958264464     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016411795678039     Document Type: Review

References (93)

1. Hall, C.B.; Weinberg, G.A.; Iwane, M.K.; Blumkin, A.K.; Edwards, K.M.; Staat, M.A.; Auinger, P.; Griffin, M.R.; Poehling, K.A.; Erdman, D.; Grijalva, C.G.; Zhu, Y. and Szilagyi, P. The Burden of Respiratory Syncytial Virus Infection in Young Children. New Engl. J. Med., 2009, 360(6), 588-598.
2. Busse, W.W. and Lemanske, R.F. Asthma. N. Engl. J. Med., 2001, 344, 350-362.
3. Serra-Battles, J.; Plaza, V.; Morejon, E.; Comella, A. and Brugues, J. Costs of Asthma according to the degree of severity. Eur. Respir. J., 1998, 12, 1322-1326.
4. Godard, P.; Chanez, P.; Siraudin, L.; Nicoloyannis, N. and Duru, G. Costs of asthma are correlated with severity. Eur. Respir. J., 2002, 19, 61-67.
5. Lopez, A.D. and Murray, C.C. The global burden of disease, 1990-2020. Nat. Med., 1998, 4(11), 1241-1243.
6. Garrood, T.; Lee, L. and Pitzalis, C. Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways. Rheumatology, 2006, 45(3), 250-260.
7. Park, H.; Li, Z.; Yang, X.O.; Chang, S.H.; Nurieva, R.; Wang, Y.H.; Wang, Y.; Hood, L.; Zhu, Z.; Tian, Q. and Dong, C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol., 2005, 6(11), 1133-1141.
8. Glezen, W.P.; Taber, L.H. and Frank, A.L. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child, 1986, 140, 543-546.
9. Shay, D.K.; Holman, R.C.; Newman, R.D.; Liu, L.L.; Stout, J.W. and Anderson, L.J. Bronchiolitis-associated hospitalizations amongUS children, 1980-1996. J. Am. Med. Assoc., 1999, 282, 1440-1446.
10. Hall, C.B.; Douglas, R.G.Jr.; Schnabel, K.C. and Geiman, J.M. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect. Immun., 1981, 33, 779-783.
11. Zhang, L.; Peeples, M.E.; Boucher, R.C.; Collins, P.L. and Pickles, R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol., 2002, 76(11), 5654-5666.
12. Aherne, W.T.; Bird, T.; Court, S.D.B.; Gardner, P.S. and McQuillin, J. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Path., 1970, 23, 7-18.
13. Welliver, T.P.; Garofalo, R.P.; Hosakote, Y.; Hintz, K.H.; Avendano, L.; Sanchez, K.; Velozo, L.; Jafri, H.; Chavez-Bueno, S.; Ogra, P.L.; McKinney, L.; Reed, J.L. and Welliver, R.C.Sr. Severe human lower respiratory tract Illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Diseases, 2007, 195(8), 1126-1136.
14. Stein, R.T.; Sherrill, D.; Morgan, W.J.; Holberg, C.J.; Halonen, M.; Taussig, L.M.; Wright, A.L. and Martinez, F.D. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. The Lancet, 1999, 354(9178), 541-545.
15. Singh, A.M.; Moore, P.E.; Gern, J.E.; Lemanske, R.F.Jr. and Hartert, T.V. Bronchiolitis to asthma: a review and call for studies of gene-virus Interactions in asthma causation. Am. J. Respir. Crit. Care Med., 2007, 175(2), 108-119.
16. Mohapatra, S.S. and Boyapalle, S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev., 2008, 21(3), 495-504.
17. Zorc, J.J. and Hall, C.B. Bronchiolitis: Recent Evidence on Diagnosis and Management. Pediatrics, 2010, 125(2), 342-349.
18. Akira, S.; Uematsu, S. and Takeuchi, O. Pathogen Recognition and Innate Immunity. Cell, 2006, 124(4), 783-801.
19. Cook, D.N.; Pisetsky, D.S. and Schwartz, D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol., 2004, 5, 975-979.
20. Liu, P.; Jamaluddin, M.; Li, K.; Garofalo, R.P.; Casola, A. and Brasier, A.R. Retinoic acid-inducible gene I mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol., 2007, 81(3), 1401-1411.
21. Rudd, B.D.; Burstein, E.; Duckett, C.S.; Li, X. and Lukacs, N.W. Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression. J. Virol., 2005, 79(6), 3350-3357.
22. Kurt-Jones, E.A.; Popova, L.; Kwinn, L.; Haynes, L.M.; Jones, L.P.; Tripp, R.A.; Walsh, E.E.; Freeman, M.W.; Golenbock, D.T.; Anderson, L.J. and Finberg, R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol., 2000, 5, 398-401.
23. Rudd, B.D.; Smit, J.J.; Flavell, R.A.; Alexopoulou, L.; Schaller, M.A.; Gruber, A.; Berlin, A.A. and Lukacs, N.W. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J. Immunol., 2006, 176(3), 1937-1942.
24. Yoneyama, M.; Kikuchi, M.; Natsukawa, T.; Shinobu, N.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Akira, S. and Fujita, T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol., 2004, 5(7), 730-737.
25. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K.J.; Yamaguchi, O.; Otsu, K.; Tsujimura, T.; Koh, C.S.; Reis e Sousa, C.; Matsuura, Y.; Fujita, T. and Akira, S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 2006, 441(7089), 101-105.
26. Kato, H.; Takeuchi, O.; Mikamo-Satoh, E.; Hirai, R.; Kawai, T.; Matsushita, K.; Hiiragi, A.; Dermody, T.S.; Fujita, T. and Akira, S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid G{cyrillic}Çôinducible gene-I and melanoma differentiationG{cyrillic}Çôassociated gene 5. J. Exp. Med., 2008, 205(7), 1601-1610.
27. Oshiumi, H.; Matsumoto, M.; Hatakeyama, S. and Seya, T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-{beta} Induction during the early phase of viral infection. J. Biol. Chem., 2009, 284(2), 807-817.
28. Seth, R.B.; Sun, L.; Ea, C.K. and Chen, Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-[kappa]B and IRF3. Cell, 2005, 122(5), 669-682.
29. Baril, M.; Racine, M.E.; Penin, F. and Lamarre, D. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J. Virol., 2009, 83(3), 1299-1311.
30. Chen, Z.J. Ubiquitin signalling in the NF-[kappa]B pathway. Nat. Cell Biol., 2005, 7(8), 758-765.
31. Brasier, A.R. The NF- κB Signaling Network: Insights from systems approaches. In Cellular Signaling And Innate Immune Responses To RNA Virus Infections, Brasier, A. R., Lemon, S. M., Garcia-Sastre, A., Eds.; American Society for Microbiology: 2008; pp 119-135.
32. Barnes, P.J. and Karin, M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 1997, 336(15), 1066-1071.
33. Liu, P.; Lu, M.; Tian, B.; Li, K.; Garofalo, R.P. and Brasier, A.R. Expression of an IKKγ splice variant determines IRF3 - canonical NF- γ B pathway utilization in ssRNA virus infection. PLoS One, 2009, 14(11), e8079.
34. Liu, P.; Choudhary, S.; Garofalo, R.P. and Brasier, A.R. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acidinducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway. J. Biol. Chem., 2008, 283, 23169-23178.
35. Tian, B.; Zhang, Y.; Luxon, B.A.; Garofalo, R.P.; Casola, A.; Sinha, M. and Brasier, A.R. Identification of NF-κB dependent gene networks in respiratory syncytial virus-infected cells. J. Virol., 2002, 76, 6800-6814.
36. Haeberle, H.; Casola, A.; Gatalica, Z.; Petronella, S.; Dieterich, H.- J.; Ernst, P.B.; Brasier, A.R. and Garofalo, R.P. IκB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J. Virol., 2004, 78, 2232-2241.
37. Kim, T.K. and Maniatis, T. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol. Cell, 1997, 1(1), 119-129.
38. Marie, I.; Durbin, J.E. and Levy, D. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J., 1998, 17(22), 6660-6669.
39. Saha, S.K.; Pietras, E.M.; He, J.Q.; Kang, J.R.; Liu, S.-Y.; Oganesyan, G.; Shahangian, A.; Zarnegar, B.; Shiba, T.L.; Wang, Y. and Cheng, G. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J., 2006, 25, 3257-3263.
40. Fitzgerald, K.A.; McWhirter, S.M.; Faia, K.L.; Rowe, D.C.; Latz, E.; Golenbock, D.T.; Coyle, A.J.; Liao, S.M. and Maniatis, T. IKK[epsi] and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol., 2003, 4(5), 491-496.
41. Imanishi, D.; Yamamoto, K.; Tsushima, H.; Miyazaki, Y.; Kuriyama, K.; Tomonaga, M. and Matsuyama, T. Identification of a novel cytokine response element inthe human IFN regulatory factor-1 gene promoter. J. Immunol., 2000, 165, 3907-3916.
42. Sharma, S.; tenOever, B.; Grandvaux, N.; Zhou, R.; Lin, R. and Hiscott, J. Triggering the interferon antiviral response through an IKK-related pathwa. Science, 2003, 300, 1148-1151.
43. Puig, O.; Caspary, F.; Riguat, G.; Rutz, B.; Bouveret, E.; Bragado-Nilsson, E.; Wilm, M. and Seraphin, B. The tandem affinity purification (TAP) method: A general procedure of protein complex purification. METHODS, 2001, 24, 218-229.
44. Bouwmeester, T.; Bauch, A.; Ruffner, H.; Angrand, P.O.; Bergamini, G.; Croughton, K.; Cruciat, C.; Eberhard, D.; Gagneur, J.; Ghidelli, S.; Hopf, C.; Huhse, B.; Mangano, R.; Michon, A.M.; Schirle, M.; Schlegl, J.; Schwab, M.; Stein, M.A.; Bauer, A.; Casari, G.; Drewes, G.; Gavin, A. C.; Jackson, D.B.; Joberty, G.; Neubauer, G.; Rick, J.; Kuster, B. and Superti-Furga, G. A physical and functional map of the human TNF-[alpha]/NF-[kappa]B signal transduction pathway. Nat. Cell Biol., 2004, 6(2), 97-105.
45. Olzewska, B.; Casola, A.; Saito, T.; Alam, R.; Crowe, S.; Mei, F.; Ogra, P.L. and Garofalo, R. Cell-specific expression of RANTES, MCP-1, and MIP-1a by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol., 1998, 72, 4756-4764.
46. Brasier, A.R.; Spratt, H.; Wu, Z.; Boldogh, I.; Zhang, Y.; Garofalo, R.P.; Casola, A.; Pashmi, J.; Haag, A.; Luxon, B. and Kurosky, A. Nuclear Heat Shock Response and Novel Nuclear Domain 10 Reorganization in Respiratory Syncytial Virus-Infected A549 Cells Identified By High Resolution 2D Gel Electrophoresis. J. Virol., 2004, 78, 11461-11476.
47. Casola, A.; Burger, N.; Liu, T.; Jamaluddin, M.; Brasier, A.R. and Garofalo, R.P. Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J. Biol. Chem., 2001, 276(23), 19715-19722.
48. Liu, T.; Castro, S.; Brasier, A.R.; Jamaluddin, M.; Garofalo, R.P. and Casola, A. Reactive oxygen species mediate virus-INDUCED STAT activation: role of tyrosine phosphatases. J. Biol. Chem., 2004, 279(4), 2461-2469.
49. Jamaluddin, M.; Tian, B.; Boldogh, I.; Garofalo, R. and Brasier, A.R. Respiratory syncyctial virus infection induces a ROS-MSK1-phospho-ser-276 RelA pathway required for cytokine expression. J. Virol., 2009, 83, 10605-10615.
50. Castro, S.M.; Guerrero-Plata, A.; Suarez-Real, G.; Adegboyega, P.A.; Colasurdo, G.N.; Khan, A.M.; Garofalo, R.P. and Casola, A. Antioxidant treatment ameliorates respiratory syncytial virusinduced disease and lung inflammation. Am. J. Respir. Crit. Care Med., 2006, 174(12), 1361-1369.
51. Hosakote, Y.M.; Liu, T.; Castro, S.M.; Garofalo, R.P. and Casola, A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am. J. Respir. Cell Mol. Biol., 2009, 41(3), 348-357.
52. Jamaluddin, M.; Wiktorowicz, J.E.; Soman, K.; Boldogh, I.; Forbus, J.; Spratt, H.; Garofalo, R.P. and Brasier, A.R. Role of peroxiredoxin-1 and -4 in protection of RSV-induced cysteinyloxidation of nuclear cytoskeletal proteins. J. Virology, 2010, submitted.
53. Boldogh, I.; Basci, A.; Choudhary, B.; Dharajiya, N.; Alam, R.; Hazdra, T.; Mitra, S.; Goldblum, R. and Sur, S. ROS generated by pollen NADPH oxidase provide a signal that augments antigeninduced allergic airway inflammation. J. Clin. Invest., 2005, 115(8), 2169-2179.
54. Role of GATA-3 in Allergic Diseases. Current Molecular Medicine 2008, 8, 330-334.
55. Barnes, P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol., 2008, 8(3), 183-192.
56. Lemanske, J. and Busse, W.W. Asthma: Clinical expression and molecular mechanisms. J. Allergy Clinical Immunol., 2010, 125(2, Supplement 2), S95-S102.
57. Pazdrak, K. Proteomics of airway inflammatory cells in asthma research. Current Proteomics, 2010, this issue.
58. Miranda, C.; Busacker, A.; Balzar, S.; Trudeau, J.; Wenzel, S.E. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J. Allergy Clinical Immunol., 2004, 113(1), 101-108.
59. Moore, W.C.; Bleecker, E.R.; Curran-Everett, D.; Erzurum, S.C.; Ameredes, B.T.; Bacharier, L.; Calhoun, W.J.; Castro, M.; Chung, K.F.; Clark, M.P.; Dweik, R.A.; Fitzpatrick, A.M.; Gaston, B.; Hew, M.; Hussain, I.; Jarjour, N.N.; Israel, E.; Levy, B.D.; Murphy, J.R.; Peters, S.P.; Teague, W.G.; Meyers, D.A.; Busse, W.W. and Wenzel, S.E. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J. Allergy Clinical Immunol., 2007, 119(2), 405-413.
60. Ad-hoc writing committee of the Assembly on AII Proceedings of the ATS Workshop on Refractory Asthma. Current Understanding, Recommendations, and Unanswered Questions. American J. Respiratory Critical Care Med. 2000, 162, 2341-2351.
61. Fahy, J.V. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc. Am. Thorac. Soc., 2009, 6(3), 256-259.
62. Wenzel, S.E.; Schwartz, L.B.; Langmack, E.L.; Halliday, J.L.; Trudeau, J.B.; Gibbs, R.L. and Chu, H.W. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med., 1999, 160(3), 1001-1008.
63. Nissen, R.M. and Yamamoto, K.R. The glucocorticoid receptor inhibits NFkappa B by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev., 2000, 14(18), 2314-2329.
64. Nowak, D.E.; Tian, B.; Jamaluddin, M.; Boldogh, I.; Vergara, L.A.; Choudhary, S.; Brasier, A.R. RelA Ser276 phosphorylation is required for activation of a subset of NF-{kappa}B-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol. Cell Biol., 2008, 28(11), 3623-3638.
65. John, M.; Lim, S.; Seybold, J.; Jose, P.; Robichaud, A.; O'Connor, B.; Barnes, P.J. and Fan, C. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein- 1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med., 1998, 157(1), 256-262.
66. Szefler, S.J. and Leung, D.Y. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur. Respir. J., 1997, 10(7), 1640-1647.
67. Xystrakis, E.; Kusumakar, S.; Boswell, S.; Peek, E.; Urry, Z.; Richards, D.F.; Adikibi, T.; Pridgeon, C.; Dallman, M.; Loke, T.K.; Robinson, D.S.; Barrat, F.J.; Garra, A.; Lavender, P.; Lee, T.H.; Corrigan, C. and Hawrylowicz, C.M. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoidresistantasthma patients. J. Clin. Invest., 2006, 116(1), 146-155.
68. Fajardo, I.; Svennson, L.; Bucht, A. and Pejler, G. Increased levelsof hypoxia-sensitive proteins in allergic airway inflammation. Am. J. Respiratory Critical Care Med., 2004, 170, 477-484.
69. Zhao, J.; Yeong, L.H. and Wong, W.S. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Int. Arch. Allergy Immunol., 2007, 142(3), 219-229.
70. Brasier, A.R.; Victor, S.; Boetticher, G.; Ju, H.; Lee, C.; Bleecker, E.R.; Castro, M.; Busse, W.W. and Calhoun, W.J. Molecular Phenotyping Of Severe Asthma Using Pattern Recognition Of Bronchoalveolar Lavage-Derived Cytokines. J. Allergy Clin. Immunol., 2008, 121, 30-37.
71. Brasier, A.R.; Victor, S.; Ju, H.; Busse, W.W.; Curran-Everett, D.; Bleecker, E.R.; Castro, M.; Chung, K.F.; Gaston, B.; Israel, E.; Wenzel, S.E.; Erzurum, S.C.; Jarjour, N. and Calhoun, W.J. Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines. Clinical and Translational Science, 2010, 3, 147-157.
72. Barnes, P.J. Chronic obstructive pulmonary Disease. New Engl. J. Med., 2000, 343(4), 269-280.
73. Silverman, E.; Chapman, H.; Drazen, J.; Weiss, S.; Osner, B.; Campbell, E.; O'Donnell, W.; Reilly, J.; Ginss, L.; Mentzer, S.; Wain, J. and Speizer, F. Genetic epidemiology of severe, earlyonset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med., 1998, 157(6), 1770-1778.
74. Cosio, M.G.; Saetta, M. and Agusti, A. Immunologic aspects of chronic obstructive pulmonary disease. New Engl. J. Med., 2009, 360(23), 2445-2454.
75. Saetta, M.; Turato, G.; Facchini, F.; Corbino, L.; Lucchini, R.; Casoni, G.; Maestrelli, P.; Mapp, C.; Ciaccia, A. and Fabbri, L. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am. J. Respir. Crit. Care Med., 1997, 156(5), 1633-1639.
76. Hwang, E.S.; Szabo, S.J.; Schwartzberg, P.L. and Glimcher, L.H. T Helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science, 2005, 307(5708), 430-433.
77. Wouters, E.F.M.; Reynaert, N.L.; Dentener, M.A. and Vernooy J.H.J. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc. Am. Thorac. Soc., 2009, 6(8), 638-647.
78. Hogg, J.C.; Chu, F.; Utokaparch, S.; Woods, R.; Elliott, W.M.; Buzatu, L.; Cherniack, R.M.; Rogers, R.M.; Sciurba, F.C.; Coxson, H.O. and Pare, P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl. J. Med., 2004, 350(26), 2645-2653.
79. Ohniski, K.; Takagi, M.; Kurokawa, Y.; Satomi, S. and Konttinen, Y.T. Matrix metalloproteinase-mdiated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest., 1998, 78, 1077-1087.
80. Pratico, D.; Basili, S.; Vieri, M.; Cordova, C.; Ioli, F. and itzgerald, G. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha -III, an index of oxidant stress. Am. J. Respir. Crit. Care Med., 1998, 158(6), 1709-1714.
81. Merckel, D.; Rist, W.; Seither, P.; Weith, A. and Lenter, M. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics, 2005, 5, 2972-2980.
82. Sepper, R. and Prikk, K. Proteomics: is it an approach to understand the progression of chronic Lung disorders? J. Proteome Res., 2004, 3(2), 277-281.
83. Zhao, Y.; Luxon, B. and Brasier, A.R. Methods for biomarker verification and assay development. Current Proteomics, 2010, this issue.
84. Riise, G.C.; Andersson, B.; Ahlstedt, S.; Enander, I.; Soderberg, M.; Lowhagen, O. and Larsson, S. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis. Eur. Respir. J., 1996, 9(8), 1665-1671.
85. Macfarlane, P.; Denham, J.; Assous, J. and Hughes, C. RSV testing in bronchiolitis: which nasal sampling method is best? Arch. Disease in Childhood, 2005, 90(6), 634-635.
86. Garofalo, R.; Kimpen, J.L.L.; Welliver, R.C. and Ogra, P.L. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatrics, 1992, 120, 28-32.
87. Garofalo, R.; Dorris, A.; Ahlstedt, S. and Welliver, R. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease. Pediatr. Allergy Immunol., 1994, 5, 111-117.
88. Pin, I.; Gibson, P.G.; Kolendowicz, R.; Girgis-Gabardo, A.; Denburg, J.A.; Hargreave, F.E. and Dolovich, J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax, 1992, 47(1), 25-29.
89. Crapo, R.O.; Jensen, R.L. and Hargreave, F.E. Airway inflammation in COPD: physiological outcome measures and induced sputum. Eur. Respir. J. Suppl., 2003, 41, 19s-28s.
90. Bronchoalveolar Lavage Cooperative Steering Committee BAL constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis., 1990, 141, S169-S202.
91. Wenzel, S.E. and Busse, W.W. Severe asthma: Lessons from the Severe Asthma Research Program. J. Allergy Clin. Immunol., 2007, 119(1), 14-21.
92. Govender, P.; Dunn, M.J. and Donnelly, S.C. Proteomics and the lung: Analysis of bronchoalveolar lavage fluid. Proteomics Clin. Applications, 2009, 3, 1044-1051.
93. Hunt, J. Exhaled breath condensate: An evolving tool for noninvasive evaluation of lung disease. J. Allergy Clin. Immunol.,2002, 110(1), 28-34.